Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Renal Cell 64Neoplasm Metastasis 25Kidney Neoplasms 21Neoplasms 16Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 13Urinary Bladder Neoplasms 12Prostatic Neoplasms 10Lung Neoplasms 8Brain Neoplasms 8Melanoma 7Colorectal Neoplasms 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Neuroendocrine Tumors 6Liver Neoplasms 6Glioblastoma 6Gastrointestinal Stromal Tumors 6Carcinoma, Hepatocellular 6Thyroid Neoplasms 5Thymoma 5Small Cell Lung Carcinoma 5Recurrence 5Multiple Myeloma 5Esophageal Neoplasms 5Carcinoma 5Uveal Melanoma 4Stomach Neoplasms 4Sarcoma 4Adenocarcinoma 4

Interventions

Carboplatin 18Paclitaxel 13Erlotinib Hydrochloride 13Bevacizumab 13Radiotherapy 12Gemcitabine 9Pemetrexed 7Cisplatin 7Gefitinib 6Docetaxel 6Taxes 4Cetuximab 4pegfilgrastim 3Radiosurgery 2Radiation 2Nivolumab 2Neoadjuvant Therapy 2Irinotecan 2Chemotherapy, Adjuvant 2Bortezomib 2pegylated granulocyte colony-stimulating factor 1lentiviral minigene vaccine of COVID-19 coronavirus 1irofulven 1cositecan 1Watchful Waiting 1Vinorelbine 1Video-Assisted Surgery 1Topotecan 1Thalidomide 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Adenocarcinoma, Bronchiolo-Alveolar × Sunitinib × Clear all
NCT00430261 2010-10-06

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

Swedish Medical Center

Phase 2 Completed
20 enrolled
Thoracic

Adenocarcinoma, Adenocarcinoma, Bronchiolo-Alveolar, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡